Skip to main content
logo
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China flag China · Delayed Price · Currency is CNY
26.56
-0.24 (-0.90%)
Apr 9, 2026, 3:00 PM CST

SHA:600196 Revenue

In the year 2025, Shanghai Fosun Pharmaceutical (Group) had annual revenue of 41.66B CNY with 1.45% growth. Shanghai Fosun Pharmaceutical (Group) had revenue of 12.27B in the quarter ending December 31, 2025, with 20.81% growth.

Revenue
41.66B
Revenue Growth
+1.45%
P/S Ratio
1.58
Revenue / Employee
1.03M
Employees
40,603
Market Cap
65.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202541.66B594.42M1.45%
Dec 31, 202441.07B-332.34M-0.80%
Dec 31, 202341.40B-2.55B-5.81%
Dec 31, 202243.95B4.94B12.66%
Dec 31, 202139.01B8.70B28.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Huadong Medicine43.09B
Yunnan Baiyao Group Co.,Ltd41.19B
China Resources Sanjiu Medical & Pharmaceutical31.60B
Humanwell Healthcare (Group)23.96B
Zhejiang NHU Company22.47B
Beijing Tongrentang17.26B
Changchun High-Tech Industry (Group)12.88B
Livzon Pharmaceutical Group12.02B
Revenue Rankings

Shanghai Fosun Pharmaceutical (Group) News

More News